Manufacturer record
D.R. Johns Lab Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by D.R. Johns Lab Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2023 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TDR-24103, Levocetirizine Tablets IP 5mg (CISTIN-L) (exp Jul 2026). Karnataka (state lab) found it not of standard quality: Description. Listed in the July 2025 alert.
Records by type
2 records linked to D.R. Johns Lab Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine Tablets IP 5mg (CISTIN-L) | Batch TDR-24103Mfg Aug 2024 · Exp Jul 2026 | DescriptionDescription | KarnatakaState lab | Jul 2025 |
| Hydroxyzine HCl IP /BP | Batch 225004010Mfg Aug 2022 · Exp Jul 2027 | Appearance of solutionOther | CDTL MumbaiCDSCO lab | Jan 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.